- Home
- BWEN vs MAIA Comparison
BWEN vs MAIA Comparison
Compare BWEN & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWEN
- MAIA
- Stock Information
- Founded
- BWEN N/A
- MAIA 2018
- Country
- BWEN United States
- MAIA United States
- Employees
- BWEN N/A
- MAIA N/A
- Industry
- BWEN Industrial Machinery/Components
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- BWEN Industrials
- MAIA Health Care
- Exchange
- BWEN Nasdaq
- MAIA Nasdaq
- Market Cap
- BWEN 49.1M
- MAIA 44.9M
- IPO Year
- BWEN N/A
- MAIA 2022
- Fundamental
- Price
- BWEN $2.29
- MAIA $1.14
- Analyst Decision
- BWEN Strong Buy
- MAIA
- Analyst Count
- BWEN 1
- MAIA 0
- Target Price
- BWEN $6.00
- MAIA N/A
- AVG Volume (30 Days)
- BWEN 297.1K
- MAIA 909.4K
- Earning Date
- BWEN 11-13-2025
- MAIA 11-07-2025
- Dividend Yield
- BWEN N/A
- MAIA N/A
- EPS Growth
- BWEN N/A
- MAIA N/A
- EPS
- BWEN N/A
- MAIA N/A
- Revenue
- BWEN $145,141,000.00
- MAIA N/A
- Revenue This Year
- BWEN $8.75
- MAIA N/A
- Revenue Next Year
- BWEN $3.50
- MAIA N/A
- P/E Ratio
- BWEN N/A
- MAIA N/A
- Revenue Growth
- BWEN N/A
- MAIA N/A
- 52 Week Low
- BWEN $1.41
- MAIA $1.12
- 52 Week High
- BWEN $3.03
- MAIA $3.48
- Technical
- Relative Strength Index (RSI)
- BWEN 51.15
- MAIA 32.62
- Support Level
- BWEN $2.18
- MAIA $1.26
- Resistance Level
- BWEN $2.37
- MAIA $1.35
- Average True Range (ATR)
- BWEN 0.19
- MAIA 0.11
- MACD
- BWEN -0.01
- MAIA -0.02
- Stochastic Oscillator
- BWEN 21.23
- MAIA 6.67
About BWEN Broadwind Inc.
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.